Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection

NCT00575185 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Infectious Mononucleosis

Interventions

DRUG: Valomaciclovir
DRUG: placebo

Sponsor

University of Minnesota

Collaborators

[object Object]